VERTEX PHARMACEUTICALS INC / MA — Director's Dealing 2012

Sep 6, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: VERTEX PHARMACEUTICALS INC / MA (VRTX)
CIK: 0000875320
Period of Report: 2012-09-04

Reporting Person: Arbuckle Stuart A (EVP\Chief Commercial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2012-09-04	Common Stock	A	9667	$0.01	Acquired	9667	Direct
2012-09-04	Common Stock	A	30000	$0.01	Acquired	39667	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2012-09-04	Employee Stock Option (right to buy)	$53.74	A	72500	Acquired	2022-09-03	Common Stock (72500)	Direct

Footnotes

F1: Restricted stock grant vesting in four annual installments on 9/30/2013, 9/30/2014, 9/30/2015 and 9/30/2016.

F2: Restricted stock grant vesting in three annual installments on 9/30/2013, 9/30/2014 and 9/30/2015.

F3: The option vests in 16 quarterly installments beginning on 12/04/2012.